Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Obesity

Free Subscription Articles published in Lancet Retrieve available abstracts of 80 articles: HTML format

Single Articles

May 2020
1. KASS DA, Duggal P, Cingolani O
   Obesity could shift severe COVID-19 disease to younger ages.
   Lancet. 2020 May 4. pii: S0140-6736(20)31024.
   PubMed    
   
   
   January 2020
2. WILLIAMS R, Aithal G, Alexander GJ, Allison M, et al
   Unacceptable failures: the final report of the Lancet Commission into liver disease in the UK.
   Lancet. 2020;395:226-239.
   PubMed     Abstract available
   
   
   December 2019
3. WELLS JC, Sawaya AL, Wibaek R, Mwangome M, et al
   The double burden of malnutrition: aetiological pathways and consequences for health.
   Lancet. 2019 Dec 13. pii: S0140-6736(19)32472.
   PubMed     Abstract available
   
   
   
4. HAWKES C, Ruel MT, Salm L, Sinclair B, et al
   Double-duty actions: seizing programme and policy opportunities to address malnutrition in all its forms.
   Lancet. 2019 Dec 13. pii: S0140-6736(19)32506.
   PubMed     Abstract available
   
   
   
5. POPKIN BM, Corvalan C, Grummer-Strawn LM
   Dynamics of the double burden of malnutrition and the changing nutrition reality.
   Lancet. 2019 Dec 13. pii: S0140-6736(19)32497.
   PubMed     Abstract available
   
   
   
6. NUGENT R, Levin C, Hale J, Hutchinson B, et al
   Economic effects of the double burden of malnutrition.
   Lancet. 2019 Dec 13. pii: S0140-6736(19)32473.
   PubMed     Abstract available
   
   
   October 2019
7. MUSELLA M, Vitiello A
   The YOMEGA non-inferiority trial.
   Lancet. 2019;394:1412.
   PubMed    
   
   
   
8. ROBERT M, Maucort-Boulch D, Delaunay D, Disse E, et al
   The YOMEGA non-inferiority trial - Authors' reply.
   Lancet. 2019;394:1412-1413.
   PubMed    
   
   
   
9. BERGEAT D, Sulpice L, Meunier B, Boudjema K, et al
   The YOMEGA non-inferiority trial.
   Lancet. 2019;394:1411-1412.
   PubMed    
   
   
   
10. EL FARA H
    The YOMEGA non-inferiority trial.
    Lancet. 2019;394:1411.
    PubMed    
    
    
    
11. THE LANCET
    Child nutrition: the need for courageous action.
    Lancet. 2019;394:1387.
    PubMed    
    
    
    
12. MYTTON OT, Fenton-Glynn C, Pawson E, Viner RM, et al
    Protecting children's rights: why governments must be bold to tackle childhood obesity.
    Lancet. 2019 Oct 10. pii: S0140-6736(19)32274.
    PubMed    
    
    
    
13. XIAO Y, Sun L
    Semaglutide in weight management.
    Lancet. 2019;394:1226.
    PubMed    
    
    
    
14. WILDING JPH
    Semaglutide in weight management - Author's reply.
    Lancet. 2019;394:1226-1227.
    PubMed    
    
    
    August 2019
15. 
    Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Lancet. 2019 Aug 29. pii: S0140-6736(19)31709.
    PubMed     Abstract available
    
    
    
16. BARNETT R
    Type 2 diabetes.
    Lancet. 2019;394:557.
    PubMed    
    
    
    
17. LEVAILLANT M, Lievre G, Baert G
    Ending diabetes in Mexico.
    Lancet. 2019;394:467-468.
    PubMed    
    
    
    July 2019
18. 
    The slowdown in eradicating hunger.
    Lancet. 2019;394:274.
    PubMed    
    
    
    April 2019
19. RENEHAN AG, Lloyd K, Renehan I
    Awareness of the link between obesity and cancer in UK school curricula.
    Lancet. 2019;393:1591-1592.
    PubMed    
    
    
    March 2019
20. MADSBAD S, Holst JJ
    Bariatric surgery-which procedure is the optimal choice?
    Lancet. 2019;393:1263-1264.
    PubMed    
    
    
    
21. MASA JF, Mokhlesi B, Benitez I, Gomez de Terreros FJ, et al
    Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial.
    Lancet. 2019 Mar 29. pii: S0140-6736(18)32978.
    PubMed     Abstract available
    
    
    
22. MURPHY PB, Piper AJ, Hart N
    Obesity hypoventilation syndrome: is less really more?
    Lancet. 2019 Mar 29. pii: S0140-6736(19)30248.
    PubMed    
    
    
    
23. AZZOPARDI PS, Hearps SJC, Francis KL, Kennedy EC, et al
    Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016.
    Lancet. 2019;393:1101-1118.
    PubMed     Abstract available
    
    
    
24. ROBERT M, Espalieu P, Pelascini E, Caiazzo R, et al
    Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.
    Lancet. 2019 Mar 6. pii: S0140-6736(19)30475.
    PubMed     Abstract available
    
    
    
25. THE LANCET
    Health and wellbeing in adolescence and early adulthood.
    Lancet. 2019;393:847.
    PubMed    
    
    
    February 2019
26. NUGENT R
    Rethinking systems to reverse the global syndemic.
    Lancet. 2019;393:726-728.
    PubMed    
    
    
    
27. DA SILVA JG
    Transforming food systems for better health.
    Lancet. 2019;393:e30-e31.
    PubMed    
    
    
    
28. MENDENHALL E, Singer M
    The global syndemic of obesity, undernutrition, and climate change.
    Lancet. 2019 Feb 11. pii: S0140-6736(19)30310.
    PubMed    
    
    
    January 2019
29. KLEINERT S, Horton R
    Obesity needs to be put into a much wider context.
    Lancet. 2019 Jan 25. pii: S0140-6736(18)33192.
    PubMed    
    
    
    
30. DAVIES R
    William Dietz: shaping science and policy on obesity.
    Lancet. 2019 Jan 25. pii: S0140-6736(19)30147.
    PubMed    
    
    
    
31. SWINBURN BA, Kraak VI, Allender S, Atkins VJ, et al
    The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report.
    Lancet. 2019 Jan 25. pii: S0140-6736(18)32822.
    PubMed    
    
    
    
32. THE LANCET
    2019: the year for nutrition.
    Lancet. 2019;393:200.
    PubMed    
    
    
    December 2018
33. SANYAL A, Charles ED, Neuschwander-Tetri BA, Loomba R, et al
    Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.
    Lancet. 2018 Dec 13. pii: S0140-6736(18)31785.
    PubMed     Abstract available
    
    
    
34. WILLIAMS R, Alexander G, Aspinall R, Batterham R, et al
    Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2018;392:2398-2412.
    PubMed     Abstract available
    
    
    November 2018
35. UNAMUNO X, Fruhbeck G
    Lorcaserin: balancing efficacy with potential risks.
    Lancet. 2018;392:2239-2240.
    PubMed    
    
    
    October 2018
36. TAYLOR R, Adamson AJ, Sattar N, Lean MEJ, et al
    VLCD for weight loss and remission of type 2 diabetes? - Authors' reply.
    Lancet. 2018;392:1307.
    PubMed    
    
    
    
37. AHMAD N, Alfaris N
    VLCD for weight loss and remission of type 2 diabetes?
    Lancet. 2018;392:1306-1307.
    PubMed    
    
    
    
38. RALSTON J, Brinsden H, Buse K, Candeias V, et al
    Time for a new obesity narrative.
    Lancet. 2018 Oct 10. pii: S0140-6736(18)32537.
    PubMed    
    
    
    
39. BOHULA EA, Scirica BM, Inzucchi SE, McGuire DK, et al
    Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32328.
    PubMed     Abstract available
    
    
    August 2018
40. O'NEIL PM, Birkenfeld AL, McGowan B, Mosenzon O, et al
    Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
    Lancet. 2018 Aug 16. pii: S0140-6736(18)31773.
    PubMed     Abstract available
    
    
    June 2018
41. RAYNER CK, Horowitz M
    Agonism of receptors in the gut-pancreas axis in type 2 diabetes: are two better than one?
    Lancet. 2018 Jun 22. pii: S0140-6736(18)30936.
    PubMed    
    
    
    
42. AMBERY P, Parker VE, Stumvoll M, Posch MG, et al
    MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
    Lancet. 2018 Jun 22. pii: S0140-6736(18)30726.
    PubMed     Abstract available
    
    
    May 2018
43. EZZATI M, Di Cesare M, Bentham J
    Determining the worldwide prevalence of obesity - Authors' reply.
    Lancet. 2018;391:1774.
    PubMed    
    
    
    
44. REILLY JJ, El-Hamdouchi A, Diouf A, Monyeki A, et al
    Determining the worldwide prevalence of obesity.
    Lancet. 2018;391:1773-1774.
    PubMed    
    
    
    
45. FLEMING TP, Watkins AJ, Velazquez MA, Mathers JC, et al
    Origins of lifetime health around the time of conception: causes and consequences.
    Lancet. 2018;391:1842-1852.
    PubMed     Abstract available
    
    
    March 2018
46. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
    Multiple sclerosis.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
    PubMed     Abstract available
    
    
    
47. BUCHBINDER R, van Tulder M, Oberg B, Costa LM, et al
    Low back pain: a call for action.
    Lancet. 2018 Mar 20. pii: S0140-6736(18)30488.
    PubMed     Abstract available
    
    
    January 2018
48. ABDULHUSSEIN D, Amin E
    Translation of the link between cancer and obesity to patients.
    Lancet. 2018;391:121-122.
    PubMed    
    
    
    
49. SELBIE D
    Reducing childhood obesity in the UK.
    Lancet. 2018;391:26.
    PubMed    
    
    
    
50. BRAILLON A
    Reducing childhood obesity in the UK and France.
    Lancet. 2018;391:26.
    PubMed    
    
    
    November 2017
51. WILLIAMS R, Alexander G, Armstrong I, Baker A, et al
    Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2017 Nov 28. pii: S0140-6736(17)32866.
    PubMed     Abstract available
    
    
    October 2017
52. THE LANCET
    The link between cancer and obesity.
    Lancet. 2017;390:1716.
    PubMed    
    
    
    
53. 
    Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32129.
    PubMed     Abstract available
    
    
    
54. DIETZ WH
    Double-duty solutions for the double burden of malnutrition.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32479.
    PubMed    
    
    
    September 2017
55. JURECIC A, Marchalik D
    On obesity: Roxane Gay's Hunger.
    Lancet. 2017;390:1577.
    PubMed    
    
    
    August 2017
56. THE LANCET
    The UK's inadequate plan for reducing childhood obesity.
    Lancet. 2017;390:822.
    PubMed    
    
    
    June 2017
57. ANGADI SS, Gaesser GA
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2285.
    PubMed    
    
    
    
58. DI ANGELANTONIO E, Bhupathiraju SN, Hu FB, Danesh J, et al
    Body-mass index and all-cause mortality - Authors' reply.
    Lancet. 2017;389:2285-2286.
    PubMed    
    
    
    
59. FLEGAL KM
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2284-2285.
    PubMed    
    
    
    
60. PEPPER DJ, Sun J, Suffredini AF, Kadri S, et al
    Body-mass index and all-cause mortality.
    Lancet. 2017;389:2284.
    PubMed    
    
    
    
61. VINER R, White B, Christie D
    Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden.
    Lancet. 2017;389:2252-2260.
    PubMed     Abstract available
    
    
    April 2017
62. KIRCHHOF P
    The future of atrial fibrillation management: integrated care and stratified therapy.
    Lancet. 2017 Apr 28. pii: S0140-6736(17)31072.
    PubMed     Abstract available
    
    
    
63. AVEYARD P, Nickless A, Jebb S
    Obesity management in primary care - Authors' reply.
    Lancet. 2017;389:1606-1607.
    PubMed    
    
    
    
64. HIGUCHI A, Kami M
    Obesity management in primary care.
    Lancet. 2017;389:1606.
    PubMed    
    
    
    
65. STURGISS EA, Haesler E, Elmitt N, Douglas K, et al
    Obesity management in primary care.
    Lancet. 2017;389:1605.
    PubMed    
    
    
    
66. BOOTH HP, Gulliford MC
    Obesity management in primary care.
    Lancet. 2017;389:1605-1606.
    PubMed    
    
    
    February 2017
67. LE ROUX CW, Astrup A, Fujioka K, Greenway F, et al
    3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
    Lancet. 2017 Feb 22. pii: S0140-6736(17)30069.
    PubMed     Abstract available
    
    
    January 2017
68. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women.
    Lancet. 2017 Jan 31. pii: S0140-6736(16)32380.
    PubMed     Abstract available
    
    
    
69. THE LANCET
    Obesity and diabetes in 2017: a new year.
    Lancet. 2017;389:1.
    PubMed    
    
    
    November 2016
70. ROYO-BORDONADA MA
    Setting up childhood obesity policies in Europe.
    Lancet. 2016;388:2475.
    PubMed    
    
    
    October 2016
71. AVEYARD P, Lewis A, Tearne S, Hood K, et al
    Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31893.
    PubMed     Abstract available
    
    
    
72. SWINBURN B, Arroll B
    Rethinking primary care systems for obesity.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31913.
    PubMed    
    
    
    
73. AVEYARD P, Lewis A, Tearne S, Hood K, et al
    Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial.
    Lancet. 2016 Oct 21. pii: S0140-6736(16)31893.
    PubMed     Abstract available
    
    
    
74. SIGMON SC
    Additive burdens of malnutrition, poverty, and substance abuse.
    Lancet. 2016;388:1879-1880.
    PubMed    
    
    
    
75. LI B, Lin R, Liu W, Chen J, et al
    Differences in perceived causes of childhood obesity between migrant and local communities in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S3.
    PubMed     Abstract available
    
    
    September 2016
76. LI F, Liu Y, Zhu W, Harmer P, et al
    China's challenges in promoting physical activity and fitness.
    Lancet. 2016;388:1278-9.
    PubMed    
    
    
    August 2016
77. MANN J, Morenga LT, McLean R, Swinburn B, et al
    Dietary guidelines on trial: the charges are not evidence based.
    Lancet. 2016;388:851-3.
    PubMed    
    
    
    
78. FREEDHOFF Y, Hall KD
    Weight loss diet studies: we need help not hype.
    Lancet. 2016;388:849-51.
    PubMed    
    
    
    
79. BERRIGAN D, Troiano RP, Graubard BI
    BMI and mortality: the limits of epidemiological evidence.
    Lancet. 2016;388:734-6.
    PubMed    
    
    
    July 2016
80. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: